Resistance, aerobic exercise improves quality of life in older long-term survivors of prostate cancer
the ONA take:
A recent study demonstrated that aerobic and resistance exercise appears to have beneficial effects on health-related quality of life (HRQoL).
The researchers examined effects, moderators, and mediators of 12 months of exercise on HRQoL in older long-term survivors.
The study included a total of 100 men who were randomized to two groups. The exercise (EX) group had 6 months of supervised aerobic and resistance exercise followed by 6 months of a home-based maintenance program.
The physical activity (PA) group were given printed material regarding physical activity for 12 months. The participants were assessed at 6 and 12 months.
The EX group demonstrated significant benefits in global QoL, physical function, and social function compared with the PA group at 6 months.
In addition, the effects on physical function were sustained at 12 months. Moderating factors included marital status, initiation of exercise sooner after diagnosis, and previous use of bisphosphonates.
Aerobic and resistance exercise appears to have beneficial effects on health-related quality of life.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|